AFB™ is a unique therapy targeting the total control of the acid-base and hydro electric balances. For decades AFB™ therapy has represented the gold standard for patient wellbeing. The number of risk patients such as elderly, diabetic and cardiopathic patients on haemodialysis is growing all the time. Conventional dialysis provides poor results for these patients, resulting in an increase in morbidity and mortality. The solution is the Acetate-free Biofiltration (AFB™), a simple and consolidated therapy using a buffer-free dialysate, a bicarbonate infusion together with the most biocompatible membrane.
Link to AFB Treatise